Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as […]

After several years of relatively little enforcement, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several […]

Join Sidley, ISS AG, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues, including: ESG and its development in the EU Seizing […]

Live Oak Workshops, in collaboration with Sidley Austin, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP […]

Deal and investment activity remains critical to the success of life sciences and healthcare innovation. RSVP Here Sidley once again brings together senior pharma, biotech, healthcare, private equity, and venture […]

Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges, and potential strategies for […]

Join us in Basel, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to […]

On February 11, Chris Boyle and Robert Darwin will participate on a panel on “Investing in Innovation: Unlocking Opportunities in the Animal Health Sector. View agenda here. This dynamic panel will […]